| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.43 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |